Drugs / CALPXT96
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02232256 | Dec 2015 → Dec 2016 | chronic pain syndrome, insomnia | 9305-9954 Quebec Inc | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CALPXT96 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02232256 ↗ |